Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs XP Inc. Class A Common Stock (XP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs XP Inc. Class A Common Stock — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $13.44 (market cap $5.85B), while XP Inc. Class A Common Stock trades at $30.27 (market cap $14.99B). The key difference: XP Inc. Class A Common Stock is far larger — about 2.6× Iovance Biotherapeutics Inc. Common Stock's market cap, and XP Inc. Class A Common Stock pays a 0.68% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and XP Inc. Class A Common Stock for 0 Days on average.
| IOVA | XP | |
|---|---|---|
Market Cap | $5.85B | $14.99B |
Volume | 14,517,176 | 14,273,752 |
Sector | Health | Financials |
52-Week High | $14.82 | $30.21 |
52-Week Low | $1.81 | $14.94 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.78B | $24.70B |
Dividend Yield | — | 0.68% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About XP Inc. Class A Common Stock
XP Inc. provides investment products and financial services in Brazil. Its platform includes brokerage, investment funds, fixed-income products, banking, insurance, and retirement solutions.
Read more on XP →
